Literature DB >> 27067497

Down syndrome in adults: a 27-year follow-up of adaptive skills.

M Arvio1,2, L Luostarinen3.   

Abstract

In 1988, we assessed the adaptive skills of 45 adults with Down syndrome (DS) (21 women and 24 men, age 20-58) with the Portage scale. Since then, we have followed them and also screened for signs of clinical dementia with the Present Psychiatric State - Learning Disabilities assessment. The mean adaptive age (AA) of the study group decreased with increasing age; the age of 35 being the turning point in the clinical course of DS. The mean AA was 4.4 years between ages 20 and 34, 3.4 years between ages 35 and 49, and 2.4 years between ages 50 and 66. Inter-individual variation was, however, large. Between ages 20 and 25, the AA of the study subjects ranged from 2.3 to 6 years; and after the age of 50, from 0.3 to 4.8 years. By the end of the study, all subjects showed signs of clinical dementia. These appeared most frequently as reduced self-care skills, loss of energy, forgetfulness, and impaired understanding. We found no connection between apolipoprotein E genotype and the clinical course of DS. We recommend follow-up of adaptive skills and screening for dementia signs in adults with DS.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Down syndrome; aging; dementia; follow-up

Mesh:

Substances:

Year:  2016        PMID: 27067497     DOI: 10.1111/cge.12787

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  3 in total

Review 1.  The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates.

Authors:  Claudio Franceschi; Paolo Garagnani; Cristina Morsiani; Maria Conte; Aurelia Santoro; Andrea Grignolio; Daniela Monti; Miriam Capri; Stefano Salvioli
Journal:  Front Med (Lausanne)       Date:  2018-03-12

2.  Signs indicating dementia in Down, Williams and Fragile X syndromes.

Authors:  Oili Sauna-Aho; Nina Bjelogrlic-Laakso; Auli Siren; Maria Arvio
Journal:  Mol Genet Genomic Med       Date:  2018-07-03       Impact factor: 2.183

Review 3.  Accelerated bio-cognitive aging in Down syndrome: State of the art and possible deceleration strategies.

Authors:  Claudio Franceschi; Paolo Garagnani; Noémie Gensous; Maria Giulia Bacalini; Maria Conte; Stefano Salvioli
Journal:  Aging Cell       Date:  2019-02-15       Impact factor: 9.304

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.